Will a bill curbing pharmaceutical monopolies become law?
Health & MedicineOne-OffPoliticsUS Politics5mo
KalshiCheck availabilityKYC required2% feeVerified resolution dataRoughly calibratedCurrent implied probabilityNo 91%
Market quality
49 / 100
Low quality24h Volume
$0
Liquidity
$1K
Low liquidityBid / Ask
3.0% / 6.3%
Spread
3.3 pt
Moderate spreadMarket data
Updated 23 minutes ago
Mar 14, 25, 2:00 PMJan 4, 27, 3:00 PM
Trends
Paper funds only — no real moneyNot financial advice
Selected outcome
Yes9%
Volume trend
$1Jul 44d of dataJul 7
Related Markets
Will the NIH indirect cost cap stick?
$1KYes: 11.4%MANIFOLD MARKETS
MANIFOLD MARKETS
Will the ACA premium tax credits be extended?
$383.9Yes: 12%KALSHI
KALSHIWill an official mugshot of Anthony Fauci be published before his death?
$200Yes: 8.3%MANIFOLD MARKETS
MANIFOLD MARKETSHow many states will legalize medical marijuana before it becomes legal federally?
$10038: 21.2%MANIFOLD MARKETS
MANIFOLD MARKETS
Who will Trump announce as next FDA commissioner?
$90.8No announcement by December 31: 26%
POLYMARKET
POLYMARKET
California Clinic Funding Proposition
$50Yes: 35%POLYMARKET
POLYMARKETActive in these topics
Related News
Polymarket: Vance leads 2028 at 19.85% as pricing trend softensBlockchain.News
White House pushes Senate Democrats to take 'historic' crypto Clarity Act ethics dealCoindesk
Senate nears bipartisan CLARITY Act deal after ethics breakthroughCrypto News
White House agrees to ethics provisions in market structure billCointelegraph
Polymarket odds show Vance at 19.85% as Epstein files critique hits tapeBlockchain.News
Dick Durbin accuses Todd Blanche of shielding Trump’s crypto empireCrypto NewsRules
If a bill titled "Patients Before Monopolies Act," or an equivalent bill aimed at curbing monopolistic practices (specifically joint ownership of PBM and Pharmacy businesses) in the healthcare or pharmaceutical industry, becomes law before Jan 4, 2027, then the market resolves to Yes.
- This market will resolve to Yes if a bill titled "Patients Before Monopolies Act" or an equivalent bill aimed at curbing monopolistic practices, specifically joint ownership of PBM and Pharmacy businesses, in the healthcare or pharmaceutical industry is signed into law by the President on or before January 3, 2027.